
Blend Therapeutics secures $16M from New Enterprise Associates, others – Washington Business Journal
Blend Therapeutics, a 1-year-old pre-clinical biotech focused on oncology drugs, has raised $16 million in Series B financing and named…
Super UserDecember 19, 2012